SAFETY AND EFFICACY OF VINORELBINE PLUS LOW-DOSE METRONOMIC CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES AND TAXANES

被引：1
|
作者：
Kudo, S. [1 ]
Makino, T. [1 ]
Hasunuma, A. [1 ]
Ahiko, Y. [1 ]
机构：
[1] Yamagata Prefectural Cent Hosp, Yamagata, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu329.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
406P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study
    Anton, Antonio
    Barnadas, Agusti
    Florian, Jesus
    Ribelles, Nuria
    Lomas, Maria
    Lao, Juan
    Gonzalez-Quintas, Ana
    Margeli, Mireia
    Paules, Ana Belen
    Gayo, Javier
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04): : 281 - 286
  • [32] Phase II study with the combination of capecitabine (C) and vinorelbine (V) in metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Estevez, LG
    Batista, N
    Sánchez-Rovira, P
    Velasco, A
    Domine, M
    Lobo, F
    Oramas, J
    Cruz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [33] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    George Orphanos
    Athanasios Alexopoulos
    Savvoula Malliou
    George Ioannidis
    Alexandros Ardavanis
    Constantinos Kandylis
    John Stavrakakis
    Gerassimos Rigatos
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 115 - 121
  • [34] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Orphanos, George
    Alexopoulos, Athanasios
    Malliou, Savvoula
    Ioannidis, George
    Ardavanis, Alexandros
    Kandylis, Constantinos
    Stavrakakis, John
    Rigatos, Gerassimos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 115 - 121
  • [35] Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes
    Wang, Junbin
    Zheng, Rongsheng
    Wang, Zishu
    Yang, Yan
    Wang, Mingxi
    Zou, Weiyan
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4657 - 4664
  • [36] Metronomic vinorelbine, cyclophosphamide plus capecitabine (VEX) combination: a phase II study for metastatic breast cancer patients
    Montagna, E.
    Palazzo, A.
    Cancello, G.
    Iorfida, M.
    Sciandivasci, A.
    Cardillo, A.
    Mazza, M.
    Munzone, E.
    Campenni, G. M.
    Bianco, N.
    Sortino, G.
    Rinaldi, L.
    Esposito, A.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
    Addeo, Raffaele
    Sgambato, Alessandro
    Cennamo, Gregorio
    Montella, Liliana
    Faiola, Vincenzo
    Abbruzzese, Alberto
    Capasso, Elena
    Leo, Luigi
    Botti, Gerardo
    Caraglia, Michele
    Del Prete, Salvatore
    CLINICAL BREAST CANCER, 2010, 10 (04) : 301 - 306
  • [38] A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
    Campone, M.
    Isambert, N.
    Bourbouloux, E.
    Roche, H.
    Bonneterre, J.
    Milano, G.
    Fumoleau, P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 871 - 879
  • [39] A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Schmid, P.
    Kuehnhardt, D.
    Kiewe, P.
    Lehenbauer-Dehm, S.
    Schippinger, W.
    Greil, R.
    Lange, W.
    Preiss, J.
    Niederle, N.
    Brossart, P.
    Freier, W.
    Kuemmel, S.
    de Velde, H. Van
    Regierer, A.
    Possinger, K.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 871 - 876
  • [40] Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
    Possinger, K
    Schippinger, W
    Kiewe, P
    Lange, W
    Preiss, J
    Niederle, N
    Brossart, P
    Papke, J
    Freier, W
    de Velde, HV
    Schmid, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 66S - 66S
12345